Safety and efficacy of ultrasound-enhanced thrombolysis in the treatment of acute middle cerebral artery infarction

A critically appraised topic

Christopher Kramer, Maria I. Aguilar, Charlene Hoffman-Snyder, Kay E. Wellik, Dean Marko Wingerchuk, Bart M Demaerschalk

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

BACKGROUND:: Despite appropriate therapy with intravenous (IV) tissue plasminogen activator (tPA), a significant proportion of patients with acute middle cerebral artery (MCA) infarction continue to suffer residual disability or death. The therapeutic use of transcranial Doppler ultrasonography (TCD) concomitantly with IV tPA is speculated to increase recanalization rates and improve clinical outcomes in patients with acute MCA stroke. OBJECTIVE:: To critically appraise the evidence concerning the safety and efficacy of the simultaneous delivery of IV tPA and continuous TCD monitoring as an acute therapy in patients with MCA territory infarction. METHODS:: The objective was addressed through the development of a structured, critically appraised topic. This incorporated a clinical scenario, background information, a structured question, literature search strategy, results, critical appraisal, clinical bottom line, and expert commentary from vascular neurology. RESULTS:: In a multicenter phase II randomized controlled study, 126 patients with acute MCA stroke were randomized to receive treatment with IV tPA and continuous TCD monitoring or placebo monitoring. Complete recanalization or dramatic clinical recovery within 2 hours after the administration of a tPA bolus occurred in 31 patients in the target group (49%), as compared with 19 patients in the control group (30%); P=0.03. At 3 months, of the patients eligible for follow-up, 22 of 53 (42%) in the target group and 14 of 49 (29%) in the control group had favorable outcomes; P=0.20. Four symptomatic intracerebral hemorrhages were noted in each group. CONCLUSIONS:: Therapeutic use of continuous TCD monitoring concomitantly with IV tPA increases recanalization rates in patients with acute MCA stroke relative to treatment with IV tPA alone without increasing the complication of intracerebral hemorrhage.

Original languageEnglish (US)
Pages (from-to)346-351
Number of pages6
JournalNeurologist
Volume17
Issue number6
DOIs
StatePublished - Nov 2011
Externally publishedYes

Fingerprint

Middle Cerebral Artery Infarction
Tissue Plasminogen Activator
Doppler Transcranial Ultrasonography
Safety
Cerebral Hemorrhage
Therapeutic Uses
Therapeutics
Control Groups
Neurology
Blood Vessels
Placebos

Keywords

  • cerebral infarction
  • fibrinolytic agents
  • intracranial embolism and thrombosis
  • middle cerebral artery
  • Stroke
  • tissue

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Safety and efficacy of ultrasound-enhanced thrombolysis in the treatment of acute middle cerebral artery infarction : A critically appraised topic. / Kramer, Christopher; Aguilar, Maria I.; Hoffman-Snyder, Charlene; Wellik, Kay E.; Wingerchuk, Dean Marko; Demaerschalk, Bart M.

In: Neurologist, Vol. 17, No. 6, 11.2011, p. 346-351.

Research output: Contribution to journalArticle

@article{b04c9d8b66e34a5b85b497d8a2ed5f84,
title = "Safety and efficacy of ultrasound-enhanced thrombolysis in the treatment of acute middle cerebral artery infarction: A critically appraised topic",
abstract = "BACKGROUND:: Despite appropriate therapy with intravenous (IV) tissue plasminogen activator (tPA), a significant proportion of patients with acute middle cerebral artery (MCA) infarction continue to suffer residual disability or death. The therapeutic use of transcranial Doppler ultrasonography (TCD) concomitantly with IV tPA is speculated to increase recanalization rates and improve clinical outcomes in patients with acute MCA stroke. OBJECTIVE:: To critically appraise the evidence concerning the safety and efficacy of the simultaneous delivery of IV tPA and continuous TCD monitoring as an acute therapy in patients with MCA territory infarction. METHODS:: The objective was addressed through the development of a structured, critically appraised topic. This incorporated a clinical scenario, background information, a structured question, literature search strategy, results, critical appraisal, clinical bottom line, and expert commentary from vascular neurology. RESULTS:: In a multicenter phase II randomized controlled study, 126 patients with acute MCA stroke were randomized to receive treatment with IV tPA and continuous TCD monitoring or placebo monitoring. Complete recanalization or dramatic clinical recovery within 2 hours after the administration of a tPA bolus occurred in 31 patients in the target group (49{\%}), as compared with 19 patients in the control group (30{\%}); P=0.03. At 3 months, of the patients eligible for follow-up, 22 of 53 (42{\%}) in the target group and 14 of 49 (29{\%}) in the control group had favorable outcomes; P=0.20. Four symptomatic intracerebral hemorrhages were noted in each group. CONCLUSIONS:: Therapeutic use of continuous TCD monitoring concomitantly with IV tPA increases recanalization rates in patients with acute MCA stroke relative to treatment with IV tPA alone without increasing the complication of intracerebral hemorrhage.",
keywords = "cerebral infarction, fibrinolytic agents, intracranial embolism and thrombosis, middle cerebral artery, Stroke, tissue",
author = "Christopher Kramer and Aguilar, {Maria I.} and Charlene Hoffman-Snyder and Wellik, {Kay E.} and Wingerchuk, {Dean Marko} and Demaerschalk, {Bart M}",
year = "2011",
month = "11",
doi = "10.1097/NRL.0b013e318236e041",
language = "English (US)",
volume = "17",
pages = "346--351",
journal = "Neurologist",
issn = "1074-7931",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Safety and efficacy of ultrasound-enhanced thrombolysis in the treatment of acute middle cerebral artery infarction

T2 - A critically appraised topic

AU - Kramer, Christopher

AU - Aguilar, Maria I.

AU - Hoffman-Snyder, Charlene

AU - Wellik, Kay E.

AU - Wingerchuk, Dean Marko

AU - Demaerschalk, Bart M

PY - 2011/11

Y1 - 2011/11

N2 - BACKGROUND:: Despite appropriate therapy with intravenous (IV) tissue plasminogen activator (tPA), a significant proportion of patients with acute middle cerebral artery (MCA) infarction continue to suffer residual disability or death. The therapeutic use of transcranial Doppler ultrasonography (TCD) concomitantly with IV tPA is speculated to increase recanalization rates and improve clinical outcomes in patients with acute MCA stroke. OBJECTIVE:: To critically appraise the evidence concerning the safety and efficacy of the simultaneous delivery of IV tPA and continuous TCD monitoring as an acute therapy in patients with MCA territory infarction. METHODS:: The objective was addressed through the development of a structured, critically appraised topic. This incorporated a clinical scenario, background information, a structured question, literature search strategy, results, critical appraisal, clinical bottom line, and expert commentary from vascular neurology. RESULTS:: In a multicenter phase II randomized controlled study, 126 patients with acute MCA stroke were randomized to receive treatment with IV tPA and continuous TCD monitoring or placebo monitoring. Complete recanalization or dramatic clinical recovery within 2 hours after the administration of a tPA bolus occurred in 31 patients in the target group (49%), as compared with 19 patients in the control group (30%); P=0.03. At 3 months, of the patients eligible for follow-up, 22 of 53 (42%) in the target group and 14 of 49 (29%) in the control group had favorable outcomes; P=0.20. Four symptomatic intracerebral hemorrhages were noted in each group. CONCLUSIONS:: Therapeutic use of continuous TCD monitoring concomitantly with IV tPA increases recanalization rates in patients with acute MCA stroke relative to treatment with IV tPA alone without increasing the complication of intracerebral hemorrhage.

AB - BACKGROUND:: Despite appropriate therapy with intravenous (IV) tissue plasminogen activator (tPA), a significant proportion of patients with acute middle cerebral artery (MCA) infarction continue to suffer residual disability or death. The therapeutic use of transcranial Doppler ultrasonography (TCD) concomitantly with IV tPA is speculated to increase recanalization rates and improve clinical outcomes in patients with acute MCA stroke. OBJECTIVE:: To critically appraise the evidence concerning the safety and efficacy of the simultaneous delivery of IV tPA and continuous TCD monitoring as an acute therapy in patients with MCA territory infarction. METHODS:: The objective was addressed through the development of a structured, critically appraised topic. This incorporated a clinical scenario, background information, a structured question, literature search strategy, results, critical appraisal, clinical bottom line, and expert commentary from vascular neurology. RESULTS:: In a multicenter phase II randomized controlled study, 126 patients with acute MCA stroke were randomized to receive treatment with IV tPA and continuous TCD monitoring or placebo monitoring. Complete recanalization or dramatic clinical recovery within 2 hours after the administration of a tPA bolus occurred in 31 patients in the target group (49%), as compared with 19 patients in the control group (30%); P=0.03. At 3 months, of the patients eligible for follow-up, 22 of 53 (42%) in the target group and 14 of 49 (29%) in the control group had favorable outcomes; P=0.20. Four symptomatic intracerebral hemorrhages were noted in each group. CONCLUSIONS:: Therapeutic use of continuous TCD monitoring concomitantly with IV tPA increases recanalization rates in patients with acute MCA stroke relative to treatment with IV tPA alone without increasing the complication of intracerebral hemorrhage.

KW - cerebral infarction

KW - fibrinolytic agents

KW - intracranial embolism and thrombosis

KW - middle cerebral artery

KW - Stroke

KW - tissue

UR - http://www.scopus.com/inward/record.url?scp=80455156391&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80455156391&partnerID=8YFLogxK

U2 - 10.1097/NRL.0b013e318236e041

DO - 10.1097/NRL.0b013e318236e041

M3 - Article

VL - 17

SP - 346

EP - 351

JO - Neurologist

JF - Neurologist

SN - 1074-7931

IS - 6

ER -